Centrally Acting Muscle Relaxants: Mechanisms, Uses & Side Effects

Centrally acting muscle relaxants—baclofen, tizanidine, cyclobenzaprine, carisoprodol, metaxalone, methocarbamol—reduce muscle tone and spasms by targeting the central nervous system.

Mechanisms (GABAergic Focus)

  1. Baclofen: GABAB agonist → presynaptic inhibition of excitatory neurotransmitter release in spinal cord and brainstem.
  2. Tizanidine: α₂-adrenergic agonist that reduces excitatory interneuron firing; also modulates GABAergic transmission.
  3. Cyclobenzaprine: Central (brainstem) noradrenergic/serotonergic modulation; structurally similar to tricyclic antidepressants.
  4. Others (metaxalone, methocarbamol, carisoprodol): Less defined; general CNS depression.

Net effect: decreased polysynaptic reflex activity → reduced muscle spasm and spasticity.

Indications

  • Acute musculoskeletal spasms (strain, sprain, back/neck pain).
  • Chronic spasticity: multiple sclerosis, spinal cord injury, cerebral palsy, stroke (baclofen, tizanidine preferred).
  • Fibromyalgia (low-dose cyclobenzaprine).
  • Adjunct to physical therapy, NSAIDs, and analgesics.

Side Effects & Safety

  • Sedation, dizziness, weakness, dry mouth, hypotension.
  • Cyclobenzaprine: anticholinergic effects (confusion in elderly), serotonin syndrome risk with serotonergic drugs.
  • Baclofen withdrawal: hallucinations, seizures, hyperthermia—taper slowly.
  • Carisoprodol: metabolized to meprobamate → abuse potential; Schedule IV.

Use the lowest effective dose; avoid in elderly (Beers criteria). Counsel against driving and alcohol use.

Muscle Strains - Related Articles